Deepak K Dalvie

US Patent:

20070004774, Jan 4, 2007

Filed:

Sep 30, 2004

Appl. No.:

10/579898

Inventors:

Deepak Dalvie - San Diego CA, US
Roger Ruggeri - San Diego CA, US

International Classification:

A61K 31/4706
C07D 215/38

US Classification:

514313000, 546159000

Abstract:

Compounds resulting from the administration of torcetrapib to a mammal, and the use of such compounds as an indicator or biomarker to the presence or exposure of torcetrapib in the plasma of a mammal including humans. The invention is also directed to cholesteryl ester transfer protein (CETP) inhibitors, pharmaceutical compositions containing such inhibitors and the use of such inhibitors to elevate certain plasma lipid levels, including high density lipoprotein (HDL)-cholesterol and to lower certain other plasma lipid levels, such as low density lipoprotein (LDL)-cholesterol and triglycerides.

US Patent:

20210403453, Dec 30, 2021

Filed:

Jun 23, 2021

Appl. No.:

17/356305

Inventors:

- Summit NJ, US
Matthew D. Correa - San Diego CA, US
Deepak Dalvie - Carlsbad CA, US
Virginia Heather Sharron Grant - San Diego CA, US
Joshua Hansen - La Jolla CA, US
Evan J. Horn - San Diego CA, US
Dehua Huang - San Diego CA, US
Christopher Mayne - Boulder CO, US
Stephen Norris - San Diego CA, US
John J. Sapienza - Chula Vista CA, US
Lida Tehrani - San Diego CA, US
Brandon W. Whitefield - San Diego CA, US

International Classification:

C07D 401/14

Abstract:

Provided herein are piperidine dione compounds having the following structure:

US Patent:

20210403454, Dec 30, 2021

Filed:

Jun 23, 2021

Appl. No.:

17/356370

Inventors:

- Summit NJ, US
Matthew D. Correa - San Diego CA, US
Deepak Dalvie - Carlsbad CA, US
Virginia Heather Sharron Grant - San Diego CA, US
Joshua Hansen - La Jolla CA, US
Evan J. Horn - San Diego CA, US
Dehua Huang - San Diego CA, US
Christopher Mayne - Boulder CO, US
Stephen Norris - San Diego CA, US
John J. Sapienza - Chula Vista CA, US
Lida Tehrani - San Diego CA, US
Brandon W. Whitefield - San Diego CA, US

International Classification:

C07D 401/14
A61P 35/00

Abstract:

Provided herein are piperidine dione compounds having the following structure:

US Patent:

20200085795, Mar 19, 2020

Filed:

May 8, 2018

Appl. No.:

16/611451

Inventors:

- Couvet, CH
Brett Skolnick - San Diego CA, US
Deepak Dalvie - Carlsbad CA, US

International Classification:

A61K 31/4245

Abstract:

Methods of treating conditions for which S1P-mediated neuroprotection is medically indicated, comprising administering to a subject in need thereof an agonist of the sphingosine 1-phosphate receptor (S1P receptor); such as a compound having the following structure (See Formula 1): or a pharmaceutically acceptable salt, stereoisomer, homolog, hydrate or solvate thereof.